AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 191 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 3.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $57,000 | -45.7% | 7,412 | -56.2% | 0.00% | 0.0% |
Q1 2020 | $105,000 | -95.6% | 16,936 | -91.4% | 0.00% | -95.2% |
Q4 2019 | $2,393,000 | -29.9% | 196,672 | -33.5% | 0.02% | -34.4% |
Q3 2019 | $3,416,000 | -38.9% | 295,798 | -47.1% | 0.03% | -36.0% |
Q2 2019 | $5,587,000 | -39.3% | 559,307 | -21.7% | 0.05% | -35.9% |
Q1 2019 | $9,202,000 | -9.2% | 714,457 | +7.1% | 0.08% | -14.3% |
Q4 2018 | $10,130,000 | +497.6% | 666,904 | +686.7% | 0.09% | +658.3% |
Q3 2018 | $1,695,000 | +9870.6% | 84,769 | +9543.8% | 0.01% | – |
Q2 2018 | $17,000 | +41.7% | 879 | +43.4% | 0.00% | – |
Q1 2018 | $12,000 | +9.1% | 613 | -28.6% | 0.00% | – |
Q4 2017 | $11,000 | 0.0% | 859 | +49.4% | 0.00% | – |
Q3 2017 | $11,000 | -98.6% | 575 | -97.1% | 0.00% | -100.0% |
Q3 2015 | $791,000 | – | 19,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,921,550 | $81,254,000 | 4.00% |
Palo Alto Investors LP | 1,614,536 | $33,453,000 | 2.49% |
Ghost Tree Capital, LLC | 100,000 | $2,072,000 | 1.46% |
March Altus Capital Management LP | 146,418 | $3,034,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 296,458 | $6,143,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,339 | $20,706,000 | 0.83% |
Visium Asset Management, LP | 2,070,870 | $42,908,000 | 0.67% |
AlphaOne Investment Services, LLC | 97,448 | $2,019,000 | 0.54% |
CONTINENTAL ADVISORS LLC | 57,438 | $1,190,000 | 0.28% |
Tamarack Capital Management, LLC | 64,080 | $1,222,000 | 0.25% |